Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zichuang Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metastable Materials Science and Technology, Applying Chemistry Key Lab of Hebei Province, Nano-Biotechnology Key Lab of Hebe…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Tumor Microenvironment, Immunogenic Cell Death. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
High level of reactive oxygen species (ROS) within the tumor microenvironment (TME) not only damage tumor cells but also diminish the efficacy of immunogenic cell death (ICD) and the activity of tumor‐infiltrating T lymphocytes, thereby limiting the effectiveness of immunotherapy. Therefore, precise modulation of ROS level is crucial to effectively eliminate tumor cells and activate ICD‐induced immunotherapy. Here, an intelligent yolk shell nanoplatform (SPCCM) that features calcium carbonate shells capable of decomposing under acidic TME conditions, thereby releasing the natural antioxidant proanthocyanidins (PAs) and the photosensitizer Ce6 is designed. PAs scavenge ROS within tumors, extending the survival time of T lymphocytes, while Ce6, as an ICD inducer, generates high ROS concentrations upon laser irradiation, thus reaching the toxic threshold within tumor cells and inducing apoptosis. The resulting apoptotic cells serve as tumor‐associated antigens, promoting dendritic cells (DCs) maturation, and activating ICD. By effectively neutralizing ROS in the TME, PAs sustainably reduce ROS level, thereby enhancing DCs activation and restoring antitumor immune cell activity suppressed by ROS (resulting in an eightfold increase in DCs activation). This study demonstrates effective synergistic effects between photodynamic therapy and immunotherapy by precisely modulating ROS level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Metastable Materials Science and Technology, Applying Chemistry Key Lab of Hebei Province, Nano-Biotechnology Key Lab of Hebei Province, Yanshan University, Qinhuangdao, 066004, China.
- Asymchem Life Science (Tianjin) Company Limited, Tianjin, 300457, P. R. China.
ORCID-Profile: Dawei Gao
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation
- Natural Science Foundation of Hebei Province
- Science Research Project of Hebei Education Department
- Science and Technology Research and Development Plan of Qinhuangdao City
- Science and Technology Plan Project of Qinhuangdao City
- Cultivation Project for Basic Research and Innovation of Yanshan University
Zitieren
APA
Xu, Z., He, Y., Zhang, X., Tu, W., Li, X., Wang, D., Yan, Y., Gao, J., Wang, D., & Gao, D. (2024). Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401741
Vancouver
Xu Z, He Y, Zhang X, Tu W, Li X, Wang D, et al. Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401741
BibTeX
@article{Xu2024,
author = {Xu, Zichuang and He, Yuchu and Zhang, Xuwu and Tu, Wenkang and Li, Xiaoling and Wang, Dong and Yan, Yaqian and Gao, Jiajun and Wang, Desong and Gao, Dawei},
title = {Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401741}
}
EUVIMED